Dentsply Sirona reports Q3 adjusted EPS 50c, consensus 47c

Reports Q3 revenue $951M, consensus $939.1M. “Q3 organic growth was driven by favorable timing in Essential Dental Solutions of approximately $20M related to stocking orders in anticipation of U.S. ERP deployment, and higher sales in CAD/CAM, which benefited from the launch of our new scanner, Primescan 2. Due to ongoing market pressures impacting equipment in the U.S., as well as the evolving landscape with Byte, we are lowering our full year organic sales outlook.” said CEO Simon Campion. “We continue to transform Dentsply Sirona (XRAY) and pivot quickly where needed. While we have more work to do, we now have multiple initiatives contributing positively to profitability and strengthening our Company’s foundation for the long term.”